First Horizon Advisors, Inc. Amphastar Pharmaceuticals, Inc. Transaction History

First Horizon Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	SELL	$38.65 - $43.48 $3,980 - $4,478	-103 Reduced 74.1%	36 $1,000
Q1 2024 Apr 26, 2024	SELL	$42.85 - $63.45 $985 - $1,459	-23 Reduced 14.2%	139 $6,000
Q4 2023 Feb 06, 2024	BUY	$44.49 - $62.93 $6,584 - $9,313	148 Added 1057.14%	162 $10,000
Q3 2023 Oct 27, 2023	BUY	$45.51 - $65.0 $637 - $910	14 New	14 $0
Q2 2022 Aug 02, 2022	BUY	$29.79 - $42.29 $714 - $1,014	24 New	24 $0

286

34.9M

74.3K

22.3K

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.92B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

Get notified when there are updates to the investment portfolio of First Horizon Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on First Horizon Advisors, Inc. with notifications on news.